Who owns TRINITY BIOTECH PLC?
- Ticker: TRIB
- CUSIP Number: 896438504
Tip: Access positions for across all investors
Analyze quarterly positions in Trinity Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Trinity Biotech stock
Who bought or sold TRINITY BIOTECH PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Hunter Associates | 661k | $251k | 23% | Jun 2026 |
|
| Williams & Novak | 141k | $55k | 31% | Jun 2026 |
|
| Susquehanna International | 77k | $30k | 435% | Jun 2026 |
|
| Moss Adams Wealth Advisors | 26k | $10k | 0% | Jun 2026 |
|
| Integrys Wealth Advisors | 25k | $8.9k | 0% | Jun 2026 |
|
| Cambridge Investment Research Advisors | 22k | $9.0k | 0% | Jun 2026 |
|
| Raymond James Financial | 20k | $7.9k | 0% | Jun 2026 |
|
| Becker Capital Management | 18k | $7.0k | 0% | Jun 2026 |
|
| LPL Financial | 18k | $6.9k | 18% | Jun 2026 |
|
| Geode Capital Management | 13k | $4.9k | -24% | Jun 2026 |
|
| Rhumbline Advisers | 9.4k | $3.6k | 69% | Jun 2026 |
|
| Jones Financial Companies, L.L | 3.6k | $1.3k | -4% | Jun 2026 |
|
| Advisor Group Holdings | 3.5k | $1.4k | 100% | Jun 2026 |
|
| Wells Fargo & Company | 2.5k | $972.000000 | 0% | Jun 2026 |
|
| Farther Finance Advisors | 2.0k | $778.000000 | 0% | Jun 2026 |
|
| UBS Group | 1.1k | $430.955100 | 10% | Jun 2026 |
|
| Triumph Capital Management | 1.0k | $542.000000 | 0% | Mar 2026 |
|
| Morgan Stanley | 402.00 | $218.004600 | -31% | Mar 2026 |
|
| Simplex Trading | 354.00 | $136.998000 | -36% | Jun 2026 |
|
| Atwood & Palmer | 20.00 | $8.000000 | 0% | Jun 2026 |
|
| McIlrath & Eck | 5.00 | $3.000000 | 100% | Mar 2026 |
|
| CoreCap Advisors | 1.00 | $0 | 0% | Jun 2026 |
|
Who sold out of Trinity Biotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Yorkville Advisors Global | Mar 2026 | 225k | $122k |
| Virtu Financial | Mar 2026 | 27k | $14k |
| Renaissance Technologies | Mar 2026 | 18k | $9.6k |
| Citadel Advisors | Mar 2026 | 14k | $7.7k |